Research Peptide Purity Standards: How to Read a Certificate of Analysis

To read a peptide Certificate of Analysis, focus on five critical elements: the batch number tying the document to your specific material, the measured HPLC purity percentage reported to at least one decimal place alongside its largest single impurity, the testing laboratory identity (third-party preferred over in-house), the mass spectrometry identity confirmation, and an independent verification mechanism that lets you confirm the results directly with the issuing lab. A COA missing any of these elements should raise immediate questions about the analytical rigor behind the product you are purchasing.

A Certificate of Analysis (COA) is the single most important document a researcher should evaluate before using any peptide compound. It is the difference between verified research-grade material and an unsubstantiated claim on a product label. Yet most researchers have never been taught how to read one critically.

This guide breaks down every section of a peptide COA, explains what the numbers actually mean, and shows you how to distinguish a legitimate third-party COA from a self-generated one that carries no real verification value.

What a Certificate of Analysis Actually Is

A COA is a document issued by an analytical laboratory confirming the identity, purity, and composition of a specific batch of a chemical compound. In the research peptide industry, the most common analysis method is High-Performance Liquid Chromatography (HPLC), which separates the components of a sample and quantifies the target compound as a percentage of total detected substances.

The reliability of that percentage is not a fixed property of HPLC. It depends on the method having been validated for the peptide in question. ICH Q2(R2), the harmonised guideline on validation of analytical procedures, requires a purity method to demonstrate specificity (that impurities are resolved from the main peak), linearity and range, accuracy by recovery, and precision as repeatability and intermediate precision, together with a quantitation limit that decides how small an impurity the method can report. An area-percent purity produced by an unvalidated method, or by a gradient too short to separate a deletion sequence from the parent peptide, can read 99% while the material is nothing of the kind. For a deeper comparison of analytical methods, see our guide on mass spectrometry in peptide purity research.

Key Sections of a Peptide COA

1. Compound Identification

The COA should clearly state the compound name, CAS registry number, and molecular formula. The CAS number is a unique numerical identifier assigned by the Chemical Abstracts Service. For example, BPC-157 carries CAS number 137525-51-0 and molecular formula C62H98N16O22. If these identifiers are missing, the COA is incomplete.

2. Batch or Lot Number

Every COA should reference a specific production batch. A COA without a batch number is a red flag. It may be a generic template rather than actual analytical data for the material you are purchasing. At Maple Research Labs, each tested batch carries a unique report number (e.g., DBAV-BPC-10-051226) that ties directly to the COA document and is printed on the product page beside the download link.

3. Purity Percentage

This is the headline number, and it is the one most often misread. There is no regulatory definition of “research grade” purity; vendors commonly report 98% or above, but the value to read is the measured figure with its decimals, not the round number in the marketing copy. Two batches both described as “98%+” can differ by more than a percentage point, and a certificate that prints “99%” with no decimal is reporting a target rather than a measurement. Read the size of the largest single impurity as well. The framework that actually governs synthetic peptides, the European Pharmacopoeia general monograph on substances for pharmaceutical use, sets thresholds for peptide-related impurities at 0.1% for reporting, 0.5% for identification and 1.0% for qualification, which means a peptide can carry a 0.4% impurity that is fully compliant and completely unidentified. A purity figure therefore tells you how much of the sample is the parent peptide; it tells you nothing about what the remainder is. Our guide to peptide impurity profiling explains the types of impurities that reduce this number and how analytical methods detect them.

4. Testing Method

The COA should specify the analytical method used. HPLC is the standard for peptide purity. Mass spectrometry (MS) is used for identity confirmation. Two supporting assays often appear alongside them on a complete report: amino acid analysis for net peptide content, which distinguishes chromatographic purity from how much peptide is actually in the vial, and endotoxin testing by LAL or recombinant Factor C, which matters for any cell-based assay. Look for method details: column type, mobile phase, detection wavelength (typically 220nm for peptides), and flow rate. These details demonstrate that the analysis was actually performed rather than fabricated.

5. Testing Laboratory Identification

This is where the critical distinction between third-party and in-house testing becomes visible. A third-party COA will identify the testing laboratory by name, with their own branding, contact information, and ideally accreditation details. An in-house COA is generated by the company selling the product, creating an inherent conflict of interest.

6. Date of Analysis

The testing date should be recent and correspond to the batch number. If a supplier is showing a COA dated two years ago for a product listed as “new batch,” the COA likely does not reflect the current material. Peptide stability degrades over time (see our peptide storage and handling guide for details), and our article on accelerated stability testing for research peptides explains the ICH guidelines governing shelf life data interpretation.

Third-Party vs. In-House Testing: Why It Matters

The clearest published evidence of what happens without independent testing comes from regulatory laboratories that buy peptide products from the open internet and analyse them. Janvier and colleagues at the Belgian official medicines control laboratory (2018, Talanta 188:795-807) profiled the ten most frequently encountered falsified peptide products purchased from three suspected illegal internet pharmacies, measuring the active ingredient, peptide-related impurities, small-molecule contaminants, elemental impurities and residual solvents. They found high variation in the amount of peptide per unit, purities as low as 5% to 75% for the cysteine-containing peptides, lead in one sample, and inorganic arsenic in multiple samples at up to ten times the ICH limit for parenteral products. An earlier screening study by the same group (Vanhee et al., 2015, Talanta 142:1-10) developed the LC-MS/MS identification method precisely because the products reaching the laboratory so often did not contain what the label claimed. None of those products came with a certificate a buyer could verify.

Independent third-party testing eliminates the conflict of interest entirely. Our detailed comparison of third-party vs in-house peptide testing explains why this distinction matters for research reliability. The testing laboratory has no financial stake in the result. At Maple Research Labs, batches submitted for testing are analysed by an independent laboratory that is identified on each report, and each report carries the laboratory’s own report number and verification details so that the result can be confirmed with the laboratory rather than with us.

How to Verify a COA

Verification is the step most researchers skip, and it is the most important. A legitimate third-party COA should be verifiable directly with the issuing laboratory, and the process is the same whoever the supplier is. Locate the report number or verification key on the COA document, together with the name and web address of the laboratory that issued it. Go to that laboratory’s own site, not to a page hosted by the supplier, and use its verification or report lookup function. The laboratory’s record should confirm the compound, the batch identifier, the purity result and the testing date, and every one of those should match the document in your hand and the label on the vial. A mismatch on any field means the certificate does not describe your material.

If a supplier cannot provide a COA with an independently verifiable result, the document carries the same evidentiary weight as the supplier’s own marketing materials: none.

Red Flags in Peptide COAs

Watch for COAs that lack a batch or lot number, fail to identify the testing laboratory (or name the supplier itself as the “laboratory”), report purity as a round number like “99%” with no decimal precision, include no chromatogram image, show a COA date that does not correspond to the batch being sold, or provide no verification mechanism for confirming results independently. Any of these gaps suggests the document may not represent genuine analytical testing of the specific batch you are purchasing.

What Maple Research Labs Provides

Where an independent laboratory report has been issued for the batch currently listed, the product page in our catalog links to it directly. Our COA index, which lists each current certificate by report number and lot alongside the compounds still awaiting one, is published at Certificates of Analysis. The reading guidance above applies to our reports exactly as it applies to anyone else’s: check the batch number on the report against the vial, and confirm the report with the laboratory that issued it.

For researchers evaluating Canadian peptide suppliers, COA transparency is the single most reliable quality signal. For a broader comparison of supplier evaluation criteria, see our guide on Canadian vs US research peptide suppliers. A supplier willing to submit its batches to independent third-party testing and publish the results publicly has nothing to hide.

A purity figure on a certificate is only as reliable as the instrument and the retained material standing behind it. Researchers reading a document closely should also review how analytical instrument qualification governs the HPLC system that produced the purity number and what retention samples make a certificate re-testable once the batch has already shipped.

A single certificate describes one batch in isolation. Two adjacent quality practices decide how far that document can be trusted across a supplier’s wider output. Annual product quality review is the formal trending of every batch of a material over a twelve month period, and skip-lot and periodic testing determines whether a result printed on the page was measured on that lot at all.

Disclaimer: All products are for research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.